Sun Young Rha

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 43

Top Topics

Epidermal Growth Factor Receptor

Renal Cell Carcinoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature communications

Scientific reports

Yonsei medical journal

This page only lists publications with an associated author ORCID identifier.

Publications

Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Yoon-Koo Kang, Hyung-Don Kim, Jeong Hwan Yook, Young-Kyu Park, Jong Seok Lee, Young-Woo Kim, Jin Young Kim, Min-Hee Ryu, Sun Young Rha, Ik Joo Chung, In-Ho Kim, Sang Cheul Oh, Young Soo Park, Jae Ho Cheong, Oh Jeong, Mi Hwa Heo, Hark Kyun Kim, ChoHyun Park, Chang Hak Yoo, Seok Yun Kang, Dae Young Zang, You-Jin Jang, Ji Young Sul, Jong Gwang Kim, Beom-Su Kim, Seung-Hoon Beom, Jun-Eul Hwang, Seung-Wan Ryu, Myeong-Cheorl Kook, Baek-Yeol Ryoo, Hyunki Kim, Moon-Won Yoo, Nam Su Lee, Sang Ho Lee, Sung Hoon Noh
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Yoon-Koo Kang, Hyung-Don Kim, Jeong Hwan Yook, Young-Kyu Park, Jong Seok Lee, Young-Woo Kim, Jin Young Kim, Min-Hee Ryu, Sun Young Rha, Ik Joo Chung, In-Ho Kim, Sang Cheul Oh, Young Soo Park, Jae Ho Cheong, Oh Jeong, Mi Hwa Heo, Hark Kyun Kim, ChoHyun Park, Chang Hak Yoo, Seok Yun Kang, Dae Young Zang, You-Jin Jang, Ji Young Sul, Jong Gwang Kim, Beom-Su Kim, Seung-Hoon Beom, Jun-Eul Hwang, Seung-Wan Ryu, Myeong-Cheorl Kook, Baek-Yeol Ryoo, Hyunki Kim, Moon-Won Yoo, Nam Su Lee, Sang Ho Lee, Sung Hoon Noh
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Hee Jin Cho, Kum-Hee Yun, Su-Jin Shin, Young Han Lee, Seung Hyun Kim, Woo-Yeol Baek, Yoon Dae Han, Sang Kyum Kim, Hyang Joo Ryu, Joohee Lee, Iksung Cho, Heounjeong Go, Jiwon Ko, Inkyung Jung, Min Kyung Jeon, Sun Young Rha, Hyo Song Kim
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial. Nature communications 15 (1) (2024)
Hee Jin Cho, Kum-Hee Yun, Su-Jin Shin, Young Han Lee, Seung Hyun Kim, Woo-Yeol Baek, Yoon Dae Han, Sang Kyum Kim, Hyang Joo Ryu, Joohee Lee, Iksung Cho, Heounjeong Go, Jiwon Ko, Inkyung Jung, Min Kyung Jeon, Sun Young Rha, Hyo Song Kim
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial. Nature communications 15 (1) (2024)
Choong-Kun Lee, Sejung Park, Chung-Mo Nam, Hyun Cheol Chung, Sun Young Rha
Reply to B. Freidlin et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Yoon-Koo Kang, Hyung-Don Kim, Jeong Hwan Yook, Young-Kyu Park, Jong Seok Lee, Young-Woo Kim, Jin Young Kim, Min-Hee Ryu, Sun Young Rha, Ik Joo Chung, In-Ho Kim, Sang Cheul Oh, Young Soo Park, Jae Ho Cheong, Oh Jeong, Mi Hwa Heo, Hark Kyun Kim, ChoHyun Park, Chang Hak Yoo, Seok Yun Kang, Dae Young Zang, You-Jin Jang, Ji Young Sul, Jong Gwang Kim, Beom-Su Kim, Seung-Hoon Beom, Jun-Eul Hwang, Seung-Wan Ryu, Myeong-Cheorl Kook, Baek-Yeol Ryoo, Hyunki Kim, Moon-Won Yoo, Nam Su Lee, Sang Ho Lee, Sung Hoon Noh
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Choong-Kun Lee, Sejung Park, Chung-Mo Nam, Hyun Cheol Chung, Sun Young Rha
Reply to B. Freidlin et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Choong-Kun Lee, Sejung Park, Chung-Mo Nam, Hyun Cheol Chung, Sun Young Rha
Reply to B. Freidlin et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Hee Jin Cho, Kum-Hee Yun, Su-Jin Shin, Young Han Lee, Seung Hyun Kim, Woo-Yeol Baek, Yoon Dae Han, Sang Kyum Kim, Hyang Joo Ryu, Joohee Lee, Iksung Cho, Heounjeong Go, Jiwon Ko, Inkyung Jung, Min Kyung Jeon, Sun Young Rha, Hyo Song Kim
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial. Nature communications 15 (1) (2024)
Seung Hyun Jung, Choong-Kun Lee, Woo Sun Kwon, Sujin Yun, Minkyu Jung, Hyo Song Kim, Hyun Cheol Chung, Yeun-Jung Chung, Sun Young Rha
Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy. Yonsei medical journal 64 (9) (2023)
Juin Park, Sun Kyoung Kang, Woo Sun Kwon, Inhye Jeong, Tae Soo Kim, Seo Young Yu, Sang Woo Cho, Hyun Cheol Chung, Sun Young Rha
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer. Scientific reports 13 (1) (2023)
Juin Park, Sun Kyoung Kang, Woo Sun Kwon, Inhye Jeong, Tae Soo Kim, Seo Young Yu, Sang Woo Cho, Hyun Cheol Chung, Sun Young Rha
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer. Scientific reports 13 (1) (2023)
Sun Young Rha, Toni K Choueiri, Vsevolod B Matveev, Anna Alyasova, Sung-Hoo Hong, Teresa Alonso Gordoa, Howard Gurney, Georg A Bjarnason, Tomas Buchler, Paolo Pedrazzoli, Toshio Takagi, Se Hoon Park, Jae Lyun Lee, Rodolfo F Perini, Cixin S He, Jodi A McKenzie, Masatoshi Eto
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial. International journal of cancer (2023)
Choong-Kun Lee, Jii Bum Lee, Se Jung Park, Jingmin Che, Woo Sun Kwon, Hyo Song Kim, Minkyu Jung, Seulkee Lee, Sook Ryun Park, Dong-Hoe Koo, Hyun Woo Lee, Woo Kyun Bae, Hei-Cheul Jeung, In Gyu Hwang, Hyunki Kim, Chung Mo Nam, Hyun Cheol Chung, Sun Young Rha
Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2023)
Kwang Seob Lee, Choong-Kun Lee, Soon Sung Kwon, Woo Sun Kwon, Sejung Park, Seung Tae Lee, Jong Rak Choi, Sun Young Rha, Saeam Shin
Clinical relevance of clonal hematopoiesis and its interference in cell-free DNA profiling of patients with gastric cancer. Clinical chemistry and laboratory medicine (2023)
Funda Meric-Bernstam, Emiliano Calvo, Keun Seok Lee, Victor Moreno, Yeon Hee Park, Sun Young Rha, Pavani Chalasani, Wei Zhong, Diansong Zhou, Steven R Pirie-Shepherd, Abraham Cf Leung, Curigliano Giuseppe
Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients With HER2-Expressing Solid Tumors: A Phase 1 Dose Escalation Study. Molecular cancer therapeutics (2023)
Juin Park, Sun Kyoung Kang, Woo Sun Kwon, Inhye Jeong, Tae Soo Kim, Seo Young Yu, Sang Woo Cho, Hyun Cheol Chung, Sun Young Rha
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer. Scientific reports 13 (1) (2023)
Juin Park, Sun Kyoung Kang, Woo Sun Kwon, Inhye Jeong, Tae Soo Kim, Seo Young Yu, Sang Woo Cho, Hyun Cheol Chung, Sun Young Rha
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer. Scientific reports 13 (1) (2023)
Choong-Kun Lee, Hyo Song Kim, Minkyu Jung, Hyunki Kim, Woo Kyun Bae, Dong-Hoe Koo, Hei Cheul Jeung, Sook Ryun Park, In Gyu Hwang, Dae Young Zang, Hyun Woo Lee, Sejung Park, Chung-Mo Nam, Hyun Cheol Chung, Sun Young Rha
Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Chang Gon Kim, Minkyu Jung, Hyo Song Kim, Choong-Kun Lee, Hei-Cheul Jeung, Dong-Hoe Koo, Woo Kyun Bae, Dae Young Zang, Bum Jun Kim, Hyunki Kim, Un-Jung Yun, Jingmin Che, Sejung Park, Tae Soo Kim, Woo Sun Kwon, Juin Park, Sang Woo Cho, Chung-Mo Nam, Hyun Cheol Chung, Sun Young Rha
Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric or Gastroesophageal Junction Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sun Young Rha, Geoffrey Y Ku, Hyo Song Kim, Hyun Cheol Chung, Fatemeh Ghazanfari Amlashi, Dipen Maheshbhai Maru, Carly A Fein, Laura H Tang, Wei Zhou, Ting Wu, Senaka A Peter, David P Kelsen, Jaffer A Ajani
PD-L1 expression and overall survival in Asian and western patients with gastric cancer. Future oncology (London, England) 18 (21) (2022)
Ho Young Yoon, Kyung Han You, Jung Hye Kwon, Jung Sun Kim, Sun Young Rha, Yoon Jung Chang, Sang-Cheol Lee
Understanding the Social Mechanism of Cancer Misinformation Spread on YouTube and Lessons Learned: Infodemiological Study. Journal of medical Internet research 24 (11) (2022)
Kwang Seob Lee, Jieun Seo, Choong-Kun Lee, Saeam Shin, Zisun Choi, Seungki Min, Jun Hyuek Yang, Woo Sun Kwon, Woobin Yun, Mi Ri Park, Jong Rak Choi, Hyun Cheol Chung, Seung Tae Lee, Sun Young Rha
Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational Burden. Clinical chemistry 68 (12) (2022)
Ho Young Yoon, Kyung Han You, Jung Hye Kwon, Jung Sun Kim, Sun Young Rha, Yoon Jung Chang, Sang-Cheol Lee
Correction: Understanding the Social Mechanism of Cancer Misinformation Spread on YouTube and Lessons Learned: Infodemiological Study. Journal of medical Internet research 24 (11) (2022)
Ryul Kim, Minae An, Hyuk Lee, Arnav Mehta, You Jeong Heo, Kyoung-Mee Kim, Song-Yi Lee, Jeonghyeon Moon, Seung Tae Kim, Byung-Hoon Min, Tae Jun Kim, Sun Young Rha, Won Ki Kang, Woong-Yang Park, Samuel J Klempner, Jeeyun Lee
Early Tumor-Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer. Cancer discovery 12 (4) (2022)
Choong-Kun Lee, Sun Young Rha, Hyo Song Kim, Minkyu Jung, Beodeul Kang, Jingmin Che, Woo Sun Kwon, Sejung Park, Woo Kyun Bae, Dong-Hoe Koo, Su-Jin Shin, Hyunki Kim, Hei-Cheul Jeung, Dae Young Zang, Sang Kil Lee, Chung Mo Nam, Hyun Cheol Chung
A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer. Nature communications 13 (1) (2022)
John L Marshall, Beth N Peshkin, Takayuki Yoshino, Jakob Vowinckel, Håvard E Danielsen, Gerry Melino, Ioannis Tsamardinos, Christian Haudenschild, David J Kerr, Carlos Sampaio, Sun Young Rha, Kevin T FitzGerald, Eric C Holland, David Gallagher, Jesús García-Foncillas, Hartmut Juhl
The Essentials of Multiomics. The oncologist 27 (4) (2022)
Chang Gon Kim, Nam Suk Sim, Jeong Eun Kim, Kum-Hee Yun, Young Han Lee, Seung Hyun Kim, Wooyeol Baek, Yoon Dae Han, Sang Kyum Kim, Ji Hyoung Kim, Yoon Woo Koh, Inkyung Jung, Su-Jin Shin, Sun Young Rha, Jin-Hee Ahn, Hyo Song Kim
Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (15) (2022)
Omer An, Yangyang Song, Xinyu Ke, Jimmy Bok-Yan So, Raghav Sundar, Henry Yang, Sun Young Rha, Ming Hui Lee, Su Ting Tay, Xuewen Ong, Angie Lay Keng Tan, Matthew Chau Hsien Ng, Erwin Tantoso, Leilei Chen, Patrick Tan, Wei Peng Yong, null null
"3G" Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy. Cancer research 81 (10) (2021)
Torben Steiniche, Sun Young Rha, Hyun Cheol Chung, Jeanette Baehr Georgsen, Morten Ladekarl, Marianne Nordsmark, Marie Louise Jespersen, Hyo Song Kim, Hyunki Kim, Carly Fein, Laura H Tang, Ting Wu, Matthew J Marton, Senaka Peter, David P Kelsen, Geoffrey Ku
Prognostic significance of T-cell-inflamed gene expression profile and PD-L1 expression in patients with esophageal cancer. Cancer medicine 10 (23) (2021)
Ji Soo Park, Eun-Ah Choe, Sejung Park, Chung-Mo Nam, Woo Jin Hyung, Sung Hoon Noh, Seoyoung Lee, Hyo Song Kim, Minkyu Jung, Hyun Cheol Chung, Sun Young Rha
Detection of asymptomatic recurrence improves survival of gastric cancer patients. Cancer medicine 10 (10) (2021)
Sun Kyoung Kang, Hyun Joo Bae, Woo Sun Kwon, Tae Soo Kim, Kyoo Hyun Kim, Sejung Park, Seo Young Yu, Jihyun Hwang, Juin Park, Hyun Cheol Chung, Sun Young Rha
Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancer. Cellular oncology (Dordrecht) 44 (6) (2021)
Yoon-Koo Kang, Jeong Hwan Yook, Young-Kyu Park, Jong Seok Lee, Young-Woo Kim, Jin Young Kim, Min-Hee Ryu, Sun Young Rha, Ik Joo Chung, In-Ho Kim, Sang Cheul Oh, Young Soo Park, Taeil Son, Mi Ran Jung, Mi Hwa Heo, Hark Kyun Kim, ChoHyun Park, Chang Hak Yoo, Jin-Hyuk Choi, Dae Young Zang, You-Jin Jang, Ji Young Sul, Jong Gwang Kim, Beom Su Kim, Seung-Hoon Beom, Sang Hee Cho, Seung-Wan Ryu, Myeong-Cheorl Kook, Baek-Yeol Ryoo, Hyun Ki Kim, Moon-Won Yoo, Nam Su Lee, Sang Ho Lee, Gyunji Kim, YeonJu Lee, Jee Hyun Lee, Sung Hoon Noh
PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (26) (2021)
Hyung Joon Kim, Mi Kyung Gong, Cheol Yong Yoon, Jaeku Kang, Mijin Yun, Nam-Hoon Cho, Sun Young Rha, Young Deuk Choi
Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells. Yonsei medical journal 61 (7) (2020)
You Jin Chun, Hei Cheul Jeung, Hyung Soon Park, Ji Soo Park, Sun Young Rha, Hye Jin Choi, Jae-Hoon Lee, Tae Joo Jeon
Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using ¹⁸F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma. Yonsei medical journal 60 (7) (2019)
Inhye Jeong, Sun Kyoung Kang, Woo Sun Kwon, Hyun Jeong Kim, Kyoo Hyun Kim, Hyun Myong Kim, Andre Lee, Suk Kyeong Lee, Thomas Bogenrieder, Hyun Cheol Chung, Sun Young Rha
Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer. Journal of cellular and molecular medicine 22 (12) (2018)
Hyun Jeong Kim, Sun Kyoung Kang, Woo Sun Kwon, Tae Soo Kim, Inhye Jeong, Hei-Cheul Jeung, Michael Kragh, Ivan D Horak, Hyun Cheol Chung, Sun Young Rha
Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor. International journal of cancer 143 (1) (2018)